These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 37321233)

  • 1. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2023 Jun; 401(10393):e21-e33. PubMed ID: 37321233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Huang L; Yao Q; Gu X; Wang Q; Ren L; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J; Wang X; Cao B
    Lancet; 2021 Aug; 398(10302):747-758. PubMed ID: 34454673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
    Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
    Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study.
    Gu X; Huang L; Cui D; Wang Y; Wang Y; Xu J; Shang L; Fan G; Cao B
    EBioMedicine; 2022 Feb; 76():103817. PubMed ID: 35074630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China.
    Zhang X; Wang F; Shen Y; Zhang X; Cen Y; Wang B; Zhao S; Zhou Y; Hu B; Wang M; Liu Y; Miao H; Jones P; Ma X; He Y; Cao G; Cheng L; Li L
    JAMA Netw Open; 2021 Sep; 4(9):e2127403. PubMed ID: 34586367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.
    Guo L; Zhang Q; Gu X; Ren L; Huang T; Li Y; Zhang H; Liu Y; Zhong J; Wang X; Chen L; Zhang Y; Li D; Fang M; Xu L; Li H; Wang Z; Li H; Bai T; Liu W; Peng Y; Dong T; Cao B; Wang J
    Lancet Microbe; 2024 Jan; 5(1):e24-e33. PubMed ID: 38048805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China.
    Zuo W; He D; Liang C; Du S; Hua Z; Nie Q; Zhou X; Yang M; Tan H; Xu J; Yu Y; Zhan Y; Zhang Y; Gu X; Zhu W; Zhang H; Li H; Sun W; Sun M; Liu X; Liu L; Cao C; Li R; Li J; Zhang Y; Zhang Y; Guo J; Zhao L; Zhang CP; Liu H; Wang S; Xiao F; Wang Y; Wang Z; Li H; Cao B
    Lancet Infect Dis; 2024 Aug; 24(8):845-855. PubMed ID: 38663423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
    Taquet M; Skorniewska Z; De Deyn T; Hampshire A; Trender WR; Hellyer PJ; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Rogers N; Houchen-Wolloff L; Greening NJ; Mansoori P; Harrison EM; Docherty AB; Lone NI; Quint J; Brightling CE; Wain LV; Evans RA; Geddes JR; Harrison PJ;
    Lancet Psychiatry; 2024 Sep; 11(9):696-708. PubMed ID: 39096931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
    Lai J; Ma S; Wang Y; Cai Z; Hu J; Wei N; Wu J; Du H; Chen T; Li R; Tan H; Kang L; Yao L; Huang M; Wang H; Wang G; Liu Z; Hu S
    JAMA Netw Open; 2020 Mar; 3(3):e203976. PubMed ID: 32202646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis.
    Zhou F; Tao M; Shang L; Liu Y; Pan G; Jin Y; Wang L; Hu S; Li J; Zhang M; Fu Y; Yang S
    Front Med (Lausanne); 2021; 8():717194. PubMed ID: 34888318
    [No Abstract]   [Full Text] [Related]  

  • 18. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort.
    González J; Benítez ID; Carmona P; Santisteve S; Monge A; Moncusí-Moix A; Gort-Paniello C; Pinilla L; Carratalá A; Zuil M; Ferrer R; Ceccato A; Fernández L; Motos A; Riera J; Menéndez R; Garcia-Gasulla D; Peñuelas O; Bermejo-Martin JF; Labarca G; Caballero J; Torres G; de Gonzalo-Calvo D; Torres A; Barbé F;
    Chest; 2021 Jul; 160(1):187-198. PubMed ID: 33676998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.